IGFBP1 and hypoalphalipoproteinemia, primary, 1: Newly diagnosed type 2 diabetes patients with FHD had significantly increased IGFBP1 DNA methylation levels compared with the patients without FHD (20.3% vs. 18.6%, P = 0.017) (Figure 2A).